Ilyin N.V., Ivanov K.I., Martynyuk T.V. New treatment options for pulmonary arterial hypertension — the first selective IP-receptor agonist selexipag. Cardiovascular Therapy and Prevention. 2019;18(6):80-87. (In Russ.) https://doi.org/10.15829/1728-8800-2019-6-80-87
Editor-in-Chief
Drapkina O. M.
Email this article (Login required)
Email the author (Login required) 101000, Moscow, Petroverigsky per., 10, str. 3
National medical research center for therapy and preventive medicine
Тел: +7 (499) 553 67 78
Editorial office Cardiovascular Therapy and Prevention
Processing of personal data
